Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

TCM Effective Against Heart Attacks and Cancer

publication date: Jun 9, 2008

A traditional Chinese medicine, red yeast rice, has been shown in a randomized, five-year study to reduce the risk of repeat heart attacks by 45%, cardiovascular mortality by 33% and cancer mortality by 66%. Red yeast rice is fermented with a mold called Monascus purpureus. It has been part of traditional Chinese medicine for centuries. The results of the trial will appear in the June 15 issue of the peer-reviewed journal, The American Journal of Cardiology.  More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital